Main Sequence Ventures manages the $240 AUD million CSIRO Innovation Fund that invests in deep tech high growth startups based out of research.
Investment Themes
Humanity Scale Healthcare
How will we diagnose and treat illness faster, cheaper + better?
Feeding 10B
People
How will we feed 10B people given planetary boundaries?
Space & New Transport
How will access to space enable new industries? How will transportation change?
New
Society
How will we learn, work, and stay safe from new threats?
Exponential Machines
How can we satisfy our appetite for connectivity and computing power?
Why We’re Different
Dedicated focus on deep tech companies with global ambitions
Unique deal flow from research relationships and strategy of company creation and spinouts
Experienced team with strong networks for deal flow, talent and coinvestment
Research Excellence
Testing & Certification
Deep Prototyping
Deep Scale Up Facilities
Who is the Fund Suitable for
The Fund is best suited to wholesale investors who:
- seek investments in early stage, high growth technology companies
- understand and are willing to accept a high level of risk for the potential to generate strong returns
- have an investment horizon greater than 10 years
- seek tax-effective investment strategies
Our Team
Alison Deans
External IC member
Bill Bartee
Managing Partner
Gabrielle Munzer
Senior Associate
Jack Steele
CSIRO IC member
Jenny Baxter
Project and Risk Manager
Martin Duursma
Partner
Mike Nicholls
Partner
Mike Zimmerman
Partner
Phil Morle
Partner
Sarah Pearson
External IC member
Stella Xu
Associate
Virginia Crawter
Senior Legal Counsel
Wholesale & Sophisticated Investors
Register to receive our Fund 2 Information Sheet.
